Table 4 The fraction of new synthesis (FNS) of palmitate, stearate, and oleate in p21 offspring and dam plasma
| Â | Â | Control | FR or Cross-over | ||||
|---|---|---|---|---|---|---|---|
| Â | Body Tissue | FNS Palmitate (%) | FNS Stearate (%) | FNS Oleate (%) | FNS Palmitate (%) | FNS Stearate (%) | FNS Oleate (%) |
Dams | Plasma p12 | 44.1 ± 1.7 | 40.9 ± 2.1 | 44.7 ± 1.7 | 44.9 ± 1.6 | 46.1 ± 2.0 | 42.3 ± 1.6 |
|  | Plasma p15 | 46.6 ± 1.6 | 42.9 ± 1.8 | 52.9 ± 2.1 | 47.3 ± 1.2 | 46.0 ± 1.9 | 50.7 ± 2.1 |
|  | Plasma p21 | 50.7 ± 2.7 | 50.2 ± 2.2 | 32.3 ± 3.2 | 53.9 ± 2.6 | 52.4 ± 3.5 | 37.3 ± 3.5 |
Offspring | SC Fat | 40.0 ± 1.4 | 22.5 ± 1.1 | 17.8 ± 1.0 | 43.5 ± 1.1* | 24.1 ± 1.0 | 17.6 ± 1.2 |
|  | RP Fat | 42.5 ± 1.3 | 25.7 ± 0.7 | 20.5 ± 0.7 | 44.1 ± 1.7 | 26.2 ± 1.2 | 19.3 ± 0.7 |
|  | Liver | 44.9 ± 0.8 | 35.3 ± 0.8 | 27.7 ± 0.2 | 46.1 ± 1.3 | 36.2 ± 1.2 | 25.9 ± 0.6 |
|  | Plasma | 39.1 ± 1.1 | 30.2 ± 0.9 | 19.8 ± 1.1 | 41.2 ± 1.3 | 30.5 ± 1.0 | 19.2 ± 1.7 |
|  | Muscle | 46.8 ± 0.8 | 30.1 ± 0.5 | 29.6 ± 0.5 | 46.7 ± 1.2 | 30.5 ± 0.9 | 27.0 ± 1.2 |